Cardiovascular Health

New research suggests that icosapent ethyl can significantly decrease cardiovascular risk among former or current smokers with other cardiovascular risk factors.

In a recent survey, researchers identified rising costs, socioeconomic inequity, and drug trends as major concerns for large employers.

The phase 2 study will evaluate the efficacy and safety of 2 different doses of MK-2060 in patients with ESRD receiving hemodialysis via an arteriovenous graft.

Analysis includes nearly 43 million individuals aged 13 year and older who received at least 1 dose in England between December 1, 2020, and December 15, 2021.

The American Heart Association includes 6 conditions and indicates that men’s and women’s experiences may differ.

Investigators reported that people who frequently naps may have an increased risk of high blood pressure and ischemic stroke by 12% compared to people who do not nap.

Advise restriction of the nutrient, along with intensive BP control, regimens promoting adherence, use of chlorthalidone in CKD.

Patients with gout have a 4 times greater risk of a cardiovascular episode within the 60 days following their flare up.

New research links some beta-blockers and antiplatelet medications with a higher risk of experiencing a heart attack in hot weather.

A daily serving of meat can increase the risk of cardiovascular disease by 22% and our own gut microbes may contribute to this risk.

A new study predicts significant increases in cardiovascular issues in the United States, highlighting racial and ethnic inequality of future patients.

Cangrelor (Kengreal) is indicated as an adjunct to percutaneous coronary intervention for reducing the risk of periprocedural myocardial infarction, repeat coronary revascularization, and stent thrombosis.

Dalteparin sodium (Fragmin) is indicated for the extended treatment of symptomatic venous thromboembolism (VTE) to reduce VTE recurrence in adult patients with cancer, as well as several other indications.

While the vaccines continue to provide critical, evidence-based protection against the coronavirus, rare cases of myocarditis and pericarditis have been reported.

Pharmacist interventions can provide patient-specific guidance to identify and solve problems with medication regimens to ensure optimal outcomes.

Ezetimibe (Zetia) is an inhibitor of intestinal cholesterol and related phytosterol absorption indicated as an adjunct to diet to reduce elevated total cholesterol.

Pharmacists have a key role in monitoring patients on statin therapy and identifying statin intolerance.

It’s common practice to recommend heart failure patients follow low sodium diets, but research has shown this type of diet may worsen patient health for certain forms of the condition.

Study shows that adult survivors of cancer had a 42% greater risk of CVD than people who did not have the disease.

Fondaparinux sodium (Arixtra) is indicated for prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip fracture surgery (including extended prophylaxis), hip replacement surgery, knee replacement surgery, or abdominal surgery.

People who performed 2 to 4 times above the recommended amount of moderate physical activity (300-600 minutes/week) saw an overall 26%-31% lower risk of mortality from all causes.

Argatroban is indicated for thrombosis in adult patients with heparin-induced thrombocytopenia and as an anticoagulant in adults patients with or at risk for HIT undergoing percutaneous coronary intervention.

Angiotensin II (Giapreza) is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock.

Findings suggest potential screening and disease detection opportunities.

Results are first to show causal relationship between losing mLOY in the blood and development of cardiovascular disease.

Women, in particular, suffer more severe cardiovascular and other complications related to diabetes.

Christopher Fine, MD, FACC, a cardiologist at National Jewish Health, discusses how pharmacists can support patients with cancer who have a much higher risk of heart disease.

Christopher Fine, MD, FACC, a cardiologist at National Jewish Health, discusses the relationship between heart disease and cancer and the importance of the field of cardio-oncology when treating patients with cancer.

Rivaroxaban is the only FDA-approved anticoagulant used in patients with peripheral artery disease and coronary artery disease.

The approval eliminates the need for traditional nitric oxide tanks in the hospital setting.